2012
DOI: 10.1007/s11136-012-0230-7
|View full text |Cite
|
Sign up to set email alerts
|

The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients

Abstract: Objective The Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) has been shown to have good psychometric performance in measuring headache impact in migraine patients, but its properties specifically in chronic migraine (CM) patients are unknown. The objective of this study was to evaluate the psychometric properties of the MSQ in a group of CM patients undergoing prophylactic treatment. Methods Measurement properties of the MSQ were examined using two international, multicenter, randomized cli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
96
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(106 citation statements)
references
References 27 publications
6
96
0
Order By: Relevance
“…With regard to the MSQ, patients reported the following scores: role‐restriction (RR = 39.6), role‐prevention (RP = 52.2), and emotional function (EF = 51.0). These scores are slightly lower compared to those reported by episodic migraine patients and to those observed by Bagley and colleagues (RR = 44.4, RP = 61.4, EF = 48.3) and Rendas‐Baums and colleagues (RR = 44.6, RP = 62.2, EF = 59.7), but are similar to those reported by Raggi and colleagues (RR = 33.2, RP = 52.2, EF = 51.0), and referred samples of patients with chronic migraine. In the study by D'Amico and colleagues, both ECH and CCH patients had lower scores on SF‐36, with a significant difference compared to the general population for most QoL domains (ie, physical, emotional, and social dimensions, and those dedicated to the personal evaluation of health status).…”
Section: Resultssupporting
confidence: 83%
“…With regard to the MSQ, patients reported the following scores: role‐restriction (RR = 39.6), role‐prevention (RP = 52.2), and emotional function (EF = 51.0). These scores are slightly lower compared to those reported by episodic migraine patients and to those observed by Bagley and colleagues (RR = 44.4, RP = 61.4, EF = 48.3) and Rendas‐Baums and colleagues (RR = 44.6, RP = 62.2, EF = 59.7), but are similar to those reported by Raggi and colleagues (RR = 33.2, RP = 52.2, EF = 51.0), and referred samples of patients with chronic migraine. In the study by D'Amico and colleagues, both ECH and CCH patients had lower scores on SF‐36, with a significant difference compared to the general population for most QoL domains (ie, physical, emotional, and social dimensions, and those dedicated to the personal evaluation of health status).…”
Section: Resultssupporting
confidence: 83%
“…Our results are consistent with MSQ v. 2.1 original study [14]. On the contrary we did not find the low relation between items 10, 11, and 12 with total scores as it was mentioned by similar studies [13, 24, 26]. …”
Section: Discussionsupporting
confidence: 92%
“…Also remarkable internal consistencies were reported for each dimension (Cronbach α = 0.84, 0.87, and 0.79 for RR, RP, and EF dimensions, resp.). Our findings match the results of prior studies, and EF dimension had the lowest Cronbach α since it had the least number of questions [13, 14, 24]. Similar to the previous study about MSQ validation for EM and CM patients, we found high internal consistency for both EM and CM patients ( α > 0.9) [25].…”
Section: Discussionsupporting
confidence: 90%
“…It assesses the everyday functioning of women over the most recent four-week period of their lives. It consists of 14 items grouped into three subscales [12, 15, 1719].

Role restriction (RR) questions 1–7 determine how the everyday activity of a patient is limited by the disease.

Role prevention (RP) questions 8–11 analyze to what extend everyday activities are disrupted by the disease or need to be ceased on its account.

Emotional function (EF) questions 12 –14 determine and evaluate the emotional dimension of the disease such as feelings of frustration or helplessness.

The usefulness of the questionnaire was determined by assessing its accuracy and reliability.…”
Section: Methodsmentioning
confidence: 99%